Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-18

Clinical Trial Update: Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 study completed comparing sevelamer carbonate powder with sevelamer hydrochloride tablets in haemodialysis patients with chronic kidney disease to demon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renagel (sevelamer)
  • Renvela (sevelamer carbonate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED